Exploring a mother-child patient population for which mothers received a flu vaccine during pregnancy to understand virus protection for the child after birth using Truveta Studio
Truveta delivers largest and most complete mother and child EHR dataset to advance healthcare
April 25, 2024 09:00 ET | Truveta
BELLEVUE, Wash., April 25, 2024 (GLOBE NEWSWIRE) -- Truveta, the company with a mission of Saving Lives with Data, announced today the largest and most complete mother-child electronic health record...
Truveta is a growing collective of health systems that provide more than 18% of all daily clinical care in the US.
CDC awards Truveta a real-world data contract to study COVID, maternal health, and pediatric care
January 22, 2024 09:00 ET | Truveta
BELLEVUE, Wash., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Today, Truveta, a growing collective of 30 health systems with a shared mission of Saving Lives with Data, was awarded a contract with the U.S....
Truveta Research on
Truveta Research on increased speech delays in children during the pandemic published in JAMA Pediatrics
December 05, 2023 09:00 ET | Truveta
BELLEVUE, Wash., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new research published in JAMA Pediatrics exploring the incidence of first-time speech delays in children under the age of...
Truveta is a growing collective of health systems that provide more than 18% of all daily clinical care in the US.
Truveta welcomes Patrick Caubel, Pfizer Chief Safety Officer, to its Board of Directors
December 04, 2023 09:00 ET | Truveta
BELLEVUE, Wash., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Truveta, the company with a mission of saving lives with data, welcomes its first member from the life science industry to its Board of Directors....
Truveta Research found that patients with overweight or obesity taking tirzepatide (Mounjaro) experienced a greater percentage change in body weight than those taking semaglutide (Ozempic) for weight loss.
Largest real-world study finds tirzepatide (Mounjaro) up to three times more effective than semaglutide (Ozempic) for weight loss
November 27, 2023 09:00 ET | Truveta
BELLEVUE, Wash., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new comparative effectiveness research exploring weight loss among patients taking semaglutide (Ozempic) and tirzepatide...
One of 2.7 million redacted echocardiogram reports available for study in Truveta.
Truveta announces availability of millions of echocardiogram reports to advance cardiovascular research
November 08, 2023 09:00 ET | Truveta
BELLEVUE, Wash., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced the availability of more than 56.6 million clinical observations from more than 2.7 million echocardiogram reports from...
Truveta is a growing collective of health systems that provide more than 18% of all daily clinical care in the US.
More than 50 organizations choose Truveta for the most complete, timely, and clean EHR data to study safety and effectiveness, improve patient care, and train medical AI
October 23, 2023 09:00 ET | Truveta
Bellevue, WASH., Oct. 23, 2023 (GLOBE NEWSWIRE) -- Truveta announced today that it is partnering with more than 50 organizations in life sciences, healthcare, government, academic medical centers,...
Truveta is a growing collective of health systems that provide more than 18% of all daily clinical care in the US
Truveta advances security and privacy with Type 2 SOC 2 examination
October 11, 2023 09:00 ET | Truveta
BELLEVUE, Wash., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Truveta today announced it has completed a Type 2 System and Organization Controls (SOC) 2 examination, which underscores Truveta’s commitments to...
Truveta and Mathematica Partnership
Truveta and Mathematica partner to advance public health and health equity with real-world data
September 21, 2023 09:00 ET | Truveta
BELLEVUE, Wash. and PRINCETON, New Jersey, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Truveta, a leading EHR data and analytics company, and Mathematica, a policy research and data analytics consultancy,...
Medical Components, Inc. and Truveta partnership
Medical Components Inc. and Truveta partner to advance care for patients living with cancer and chronic kidney disease
September 12, 2023 09:00 ET | Truveta
BELLEVUE, Wash., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Medical Components, Inc. is partnering with Truveta to advance the use of real-world data to improve clinical care for patients battling cancer...
Next Page keyboard_arrow_right